Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study

被引:19
作者
Matsuhashi, Nobuyuki [1 ]
Kudo, Mineo [2 ]
Yoshida, Norimasa [3 ]
Murakami, Kazunari [4 ]
Kato, Mototsugu [5 ]
Sanuki, Tsuyoshi [6 ]
Oshio, Atsushi [7 ]
Joh, Takashi [8 ,9 ]
Higuchi, Kazuhide [9 ,10 ]
Haruma, Ken [9 ,11 ]
Nakada, Koji [9 ,12 ]
机构
[1] NTT Med Ctr Tokyo, Dept Gastroenterol, Shinagawa Ku, Tokyo 1418625, Japan
[2] Sapporo Hokuyu Hosp, Dept Gastroenterol, Shiroishi Ku, Sapporo, Hokkaido 0030006, Japan
[3] Japanese Red Cross Kyoto Daiichi Hosp, Dept Gastroenterol, Higashiyama Ku, Kyoto 6050981, Japan
[4] Oita Univ Hosp, Dept Gastroenterol, Oita 8795593, Japan
[5] Hokkaido Univ Hosp, Div Endoscopy, Kita Ku, Sapporo, Hokkaido 0608648, Japan
[6] Kita Harima Med Ctr, Dept Gastroenterol, Ono, Hyogo 6751392, Japan
[7] Waseda Univ, Fac Letters Arts & Sci, Shinjuku Ku, Tokyo 1628644, Japan
[8] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[9] GERD Soc Study Comm, Kita Ku, Osaka 5300005, Japan
[10] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 5698686, Japan
[11] Kawasaki Med Sch, Dept Internal Med, Div Gastroenterol, Kurashiki, Okayama 7010192, Japan
[12] Jikei Univ, Sch Med, Dept Surg, Minato Ku, Tokyo 1058461, Japan
关键词
Gastroesophageal reflux disease; Dyspeptic symptoms; Depression; Anxiety; Therapeutic response to proton pump inhibitor therapy; QUALITY-OF-LIFE; IBS PATIENTS; SYMPTOM; RELIEF; PREDICTION; GUIDELINES; MANAGEMENT; FREQUENCY; DIAGNOSIS; TRIAL;
D O I
10.1007/s00535-015-1073-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Proton pump inhibitor (PPI) therapy, the first-line treatment for gastroesophageal reflux disease (GERD), is not always effective. This study aimed to examine the effect of pretreatment patient characteristics on response to PPI therapy. Methods Japanese outpatients with symptomatic GERD scheduled to receive endoscopy and PPI therapy were enrolled in this multicenter prospective observational study. The patients' characteristics, including GERD and dyspeptic symptoms, anxiety, depression, and quality of life, were assessed using questionnaires before and 2 and 4 weeks after the start of PPI therapy. Factors affecting therapeutic response were examined by simple and multiple regression analyses using three patient-reported outcome measures as objective variables. Results Data from 182 patients were analyzed. In multiple regression analysis using the residual symptom rate as an objective variable, lower GERD symptom score (p < 0.05), absence of erosive esophagitis (p < 0.05), higher epigastric pain/burning symptom score (p < 0.05), and higher depression subscale score (p < 0.05) accompanied poorer therapeutic response. In analyses using the patient's impression of therapy, lower GERD symptom score (p < 0.05) and absence of erosive esophagitis (p < 0.05) accompanied poorer therapeutic response. In analyses using the relative GERD symptom intensity evaluated using a numeric rating scale, lower GERD symptom score (p < 0.05), higher epigastric pain/burning symptom score (p < 0.1), and lower body mass index (p < 0.05) accompanied poorer therapeutic response. Conclusions Patients who complained of milder GERD symptoms before treatment were likely to have poorer response to PPI therapy. Association of absence of erosive esophagitis, severer epigastric pain/burning symptoms, lower body mass index, and severer depression with poorer therapeutic response was also suggested.
引用
收藏
页码:1173 / 1183
页数:11
相关论文
共 29 条
[1]   Review article: endpoints used in functional dyspepsia drug therapy trials [J].
Ang, D. ;
Talley, N. J. ;
Simren, M. ;
Janssen, P. ;
Boeckxstaens, G. ;
Tack, J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (06) :634-649
[2]   Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients [J].
Bytzer, P .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (03) :S31-S39
[3]   Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis [J].
Chiba, N ;
DeGara, CJ ;
Wilkinson, JM ;
Hunt, RH .
GASTROENTEROLOGY, 1997, 112 (06) :1798-1810
[4]   A POWER PRIMER [J].
COHEN, J .
PSYCHOLOGICAL BULLETIN, 1992, 112 (01) :155-159
[5]   Effectiveness of Proton Pump Inhibitors in Nonerosive Reflux Disease [J].
Dean, Bonnie B. ;
Gano, Anacleto D., Jr. ;
Knight, Kevin ;
Ofman, Joshua J. ;
Fass, Ronnie .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (08) :656-664
[6]  
Fukuhara S., 2004, Manual of the SF-8 Japanese Version
[7]   Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan [J].
Furuta, Takahisa ;
Shimatani, Tomohiko ;
Sugimoto, Mitsushige ;
Ishihara, Shunji ;
Fujiwara, Yasuhiro ;
Kusano, Motoyasu ;
Koike, Tomoyuki ;
Hongo, Michio ;
Chiba, Tsutomu ;
Kinoshita, Yoshikazu .
JOURNAL OF GASTROENTEROLOGY, 2011, 46 (11) :1273-1283
[8]   Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole [J].
Heading, Robert C. ;
Moennikes, Hubert ;
Tholen, Anne ;
Schmitt, Holger .
BMC GASTROENTEROLOGY, 2011, 11
[9]  
Hershcovici Tiberiu, 2010, J Neurogastroenterol Motil, V16, P8, DOI 10.5056/jnm.2010.16.1.8
[10]   Minimal changes in reflux esophagitis: red ones and white ones [J].
Hongo, M .
JOURNAL OF GASTROENTEROLOGY, 2006, 41 (02) :95-99